CA
CLB icon

Crewe Advisors’s Core Laboratories CLB Stock Holding History

Crewe Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-526
Closed -$10.7K – 765
2024
Q2 		$10.7K Buy
526
+406
+338% +$7.18K ﹤0.01% 678
2024
Q1 		$2.05K Buy
+120
New +$1.89K ﹤0.01% 853
2023
Q3 		– Sell
-5
Closed -$117 – 646
2023
Q2 		$117 Buy
+5
New +$113 ﹤0.01% 847
2020
Q4 		– Sell
-166
Closed -$3K – 485
2020
Q3 		$3K Buy
+166
New +$3.48K ﹤0.01% 432

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Crewe Advisors's CLB Position: Q3 2024 in Review

Crewe Advisors sold out of Core Laboratories (CLB) in Q3 2024, closing a stake of 526 shares — an estimated $10.7K sold.

Crewe Advisors first reported a position in CLB in Q3 2020 and held it in 4 quarters. The position peaked at $10.7K in Q2 2024. 191 funds tracked by Wall St. Rank hold CLB as of Q3 2024.

  • Crewe Advisors reported no remaining Core Laboratories position as of Q3 2024 after selling out during the quarter.
  • Crewe Advisors sold 526 Core Laboratories shares in Q3 2024, an estimated $10.7K.
  • Crewe Advisors first reported a position in Core Laboratories in Q3 2020 and held it in 4 quarters.
  • Crewe Advisors's Core Laboratories position peaked at $10.7K in Q2 2024.
  • 191 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2024.

Based on Crewe Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.